An Automatically Adjusting Prosthetic Socket for People With Transtibial Amputation
Launched by UNIVERSITY OF WASHINGTON · Nov 5, 2021
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of prosthetic socket designed for people who have had a leg amputated below the knee. Many amputees experience daily changes in the size of their residual limb, which can make their prosthesis uncomfortable or even painful. The goal of this research is to develop a prosthetic socket that automatically adjusts to fit these size changes throughout the day, helping to improve comfort and reduce issues like pain or skin problems.
To participate in this trial, you need to be at least 18 years old and have had a transtibial (below-the-knee) amputation for at least a year. You should also regularly use a definitive prosthesis that fits well and not have any serious skin issues or conditions that affect your sensation. Participants can expect to test this innovative socket and provide feedback on its comfort and effectiveness. This trial is currently recruiting participants of all genders who are looking for a better solution to manage their prosthetic fit throughout the day.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 or older (Prosthetists and Prosthesis Users)
- • must have certification and regularly treat patients with trans-tibial limb loss in a clinical setting (Prosthetists only)
- • had a trans-tibial amputation at least 12 months prior (prosthesis users only)
- • regularly use a definitive prosthesis with pin lock suspension and few or no pads (prosthesis users only)
- • self-report experiencing limb volume fluctuation in the past (prosthesis users only)
- • have residual limb length of at least 9 cm (prosthesis users, Aim 2 and Aim 3 only)
- • walk at least 5 continuous minutes and intermittently at least 1 hour (prosthesis users, Aim 2 and Aim 3 only)
- • capable of distinguishing socket sizes too large and too small to be tolerated (Prosthetists and Prosthesis Users)
- Exclusion Criteria:
- • Are not certified prosthetists (prosthetists only)
- • neuropathy (prosthesis users only)
- • reduced skin sensation (prosthesis users only)
- • regular use of an assisted device (prosthesis users only)
- • sores or skin breakdown on their residual limb (prosthesis users, Aim 2 and Aim 3 only)
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Joan E Sanders, PhD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials